EN

CN

API
HOME > Product > API > Daptomycin

Daptomycin

Code
Name Daptomycin
CAS No. 103060-53-3
Sepcification Enterprise standard
Usage and indications Daptomycin is indicated for use in adults for skin and skin structure infections caused by Gram-positive infections, S. aureus bacteraemia, and right-sided S. aureus endocarditis. It binds avidly to pulmonary surfactant, so cannot be used in the treatment of pneumonia. There seems to be a difference in working daptomycin on hematogenous pneumonia.
Structural formaula
Description

1. Dosage form and Mechanism of action

KR: 답토마이신

JPN: ダプトマイシン

Dosage form: Injection

Mechanism of action: Daptomycin has a distinct mechanism of action, disrupting multiple aspects of bacterial cell membrane function. It inserts into the cell membrane in a phosphatidylglycerol-dependent fashion, where it then aggregates. The aggregation of daptomycin alters the curvature of the membrane, which creates holes that leak ions. This causes rapid depolarization, resulting in a loss of membrane potential leading to inhibition of protein, DNA, and RNA synthesis, which results in bacterial cell death.


2. Specification

Regarding the detailed standard, please contact info@shjnj.com


3. Package

1 kg/bag; 5 kgs/bag;

It can also be packed according to the requirements


4. Product source

Produced by fermentation in China


5. Document support

SMF and DMF are available


6. Supply

    Annual capacity: 5 MT; Stable supply for more than 10 years



If you need, Please contact us:info@shjnj.com


Add:402, Building 23, No.588, Xinjunhuan Rd. Minhang, Shanghai 201114, CN

Post Code:201114 Tel:021-50911366 Fax:021-50911377

沪ICP备18015790号